THTX upgraded at Research Capital - Cantech Letter
| TH Stock | CAD 1.67 0.01 0.60% |
About 62% of Theratechnologies' investor base is looking to short. The analysis of the overall investor sentiment regarding Theratechnologies suggests that many traders are alarmed. Theratechnologies' investing sentiment overview a quick insight into current market opportunities from investing in Theratechnologies. Many technical investors use Theratechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Theratechnologies |
THTX upgraded at Research Capital Cantech Letter
Read at news.google.com
 |
Theratechnologies Fundamental Analysis
We analyze Theratechnologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theratechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theratechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Theratechnologies is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Theratechnologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theratechnologies stock to make a market-neutral strategy. Peer analysis of Theratechnologies could also be used in its relative valuation, which is a method of valuing Theratechnologies by comparing valuation metrics with similar companies.
Peers
Theratechnologies Related Equities
| ERE-UN | European Residential | 1.66 | ||||
| ALA-PA | Altagas Cum | 1.00 | ||||
| XEG | IShares SPTSX | 0.49 | ||||
| XHB | IShares Canadian | 0.15 | ||||
| RUDB | RBC Discount | 0.23 | ||||
| APS | Aptose Biosciences | 20.59 |
Check out Theratechnologies Hype Analysis, Theratechnologies Correlation and Theratechnologies Performance. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.